-7.58% for Injective — sellers dominate amid oversold technical signals

Traders Union
All News
Crypto News
Injective slips 7.58% to $4.63 today

Highlights

INJ trades at $4.63, below the MA-20 ($5.57), MA-50 ($6.35), and MA-200 ($10.88), signaling widespread bearish pressure across all timeframes.
Momentum and oscillators, including MACD, ADX, RSI (34.19), Stoch RSI (0.00), and CCI (−170.42), all confirm an oversold, strongly bearish environment with sellers in control.
INJ fell 7.58% today, with price expected to consolidate between $4.15 and $4.85 in the next five days and more than 80% chance of further declines.

Oversold momentum deepens as multiple indicators confirm downside

Technical conditions for INJ remain negative, with dynamic resistance marked by the Ichimoku Kijun at $5.57 and support anchored at recent lows, rather than at any moving average or Ichimoku line. Bearish momentum is confirmed by the daily MACD and ADX, both indicating continued downside and a weak trend. Oscillator readings — including RSI at 34.19, Stoch RSI at 0.00, and CCI at −170.42 — suggest the asset is significantly oversold, a view reinforced by a strongly negative BBP (−0.36) and the Awesome Oscillator. Price action following the open reflected high volatility and pronounced downside alignment with ongoing negative momentum.

Bearish continuation seen as volatility and downside risk remain high

For the next five trading days, INJ is likely to consolidate in a volatility band between $4.15 and $4.85, reflecting the current elevated volatility and pressure from sellers. There is a more than 80% probability of further declines and a lower likelihood of a rebound. A sustained move above $4.85 could prompt a recovery toward $5.57 resistance, while a break below $4.15 would open up further downside toward support near recent lows.

Anton Kharitonov, expert at Traders Union, sees INJ stuck in a persistent bearish trend as technical indicators confirm downside momentum and oversold conditions. He notes that without supportive news or positive catalysts, the risk of deeper declines stays elevated. Kharitonov believes price may consolidate between $4.15 and $4.85, but the outlook remains clearly defensive until buyers reclaim higher levels. "Base case remains downside — as long as INJ trades below $4.85, recovery attempts should be viewed with skepticism."

Last time, analysts noted that Injective remains under downside pressure, trading below all major moving averages while momentum indicators such as MACD and ADX signal a persistent bearish environment despite multiple oversold readings on the RSI and other oscillators. Immediate resistance lies at the Ichimoku Kijun level, and unless this is reclaimed, the price is likely to consolidate or extend losses within the specified range.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.